Psychiatr. pro Praxi, 2010; 11(1): 11-14

What really works in anxiety disorders: we’ll add an exercise to the therapeutic combinations

MUDr.Jiřina Kosová
Psychiatrické centrum Praha

Anxiety disorders are very common and burdensome conditions with lifetime prevalence about 30 %. Experimental evidence supports

both psychotherapy as well as pharmacotherapy as effective treatment. There might be some evidence for superiority of combination

therapy under some condition, e.g. in the acute and maintenance phase of treatment of panic disorder, social phobia, or obsessive

compulsive disorder.

Third important part of the treatment combinations should be a physical activity. Physical activity (mainly aerobic exercise) is associated

with range of health benefits; its absence can have harmful effects on health (increasing the risk for coronary heart disease, diabetes,

hypertension, obesity, cancer), and may also be associated with the development of mental disorders. It is clear, that physical activity

and exercise have the positive effects on mood and anxiety in both clinical and nonclinical populations. The mechanisms responsible for

exercise-related improvements in anxiety disorders are not all known, and it is most likely to be a complex interaction of psychological

and neurobiological mechanisms underlying, mediating and/or moderating these effects.

Keywords: treatment of anxiety disorders, combination of psychotherapy and pharmacotherapy, physical activity, exercise

Published: January 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kosová J. What really works in anxiety disorders: we’ll add an exercise to the therapeutic combinations. Psychiatr. praxi. 2010;11(1):11-14.
Download citation

References

  1. Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe - A critical review and appraisal of 27 studies. Europian Neuropsychopharmacology 2005; 15: 357-376. Go to original source... Go to PubMed...
  2. Kessler RC, Chiu WT, Merikangas KR, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005; 62: 617-627. Go to original source... Go to PubMed...
  3. Costello EJ, Ether H, Angold A. The developmental epidemiology of anxiety disorders: Phenomenology, prevalence, and comorbidity. Child and Adolescent Psychiatric Clinics of North America 2005; 14: 631-648. Go to original source... Go to PubMed...
  4. Durham RC, Chambers JA, Power KG, et al. Long-term outcome of cognitive behavior therapy clinical trials in central Scotland. Health Technol Assess 2005; 9(42): 1-174. Go to original source... Go to PubMed...
  5. Barlow DH. Anxiety and its disorders: The nature and treatment of anxiety and panic. New York, Guilford 2002.
  6. Marcus SM, Gorman J, Shear MK, et al. A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapy. Am J psychiatry 2007; 164: 273-275. Go to original source... Go to PubMed...
  7. Foa EB, Franklin ME, Moser J. Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination? Biol Psychiatry 2002; 52: 987-997. Go to original source... Go to PubMed...
  8. Bandelow B, Seidler-Brandler U, Becker A, et al. Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders. World J Biol Psychiatry 2007; 8: 175-187. Go to original source... Go to PubMed...
  9. Furukawa TA, Watanabe N, Churchill R. Combined psychotherapy and antidepressants for panic disorder with or without agoraphobia. Cochrane Database Syst Rev 2007; CD 004364. Go to original source... Go to PubMed...
  10. Barlow DH, Gorman JM, Shear MK, et al. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 2000; 283: 2529-2536. Go to original source... Go to PubMed...
  11. Biondi M, Picardi A. Increased maintenance of obsessive - compulsive disorder remission after integrated serotonergic treatment and cognitive psychotherapy compared with medication alone. Psychoher Psychosom 2005; 74: 123-128. Go to original source... Go to PubMed...
  12. Parnas AS, Weber M, Richardson R. Effects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats. Neurobiol Learn Mem 2005; 83: 224-231. Go to original source... Go to PubMed...
  13. Ressler KJ, Rothbaum BO, Tannenbaum L, et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004; 61: 1136-1144. Go to original source... Go to PubMed...
  14. Hofmann SG, Meuret AE, Smits JA, et al. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry 2006; 63: 298-304. Go to original source... Go to PubMed...
  15. Guastella AJ, Richardson R, Lovibond PF, et al. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry 2008; 63: 544-549. Go to original source... Go to PubMed...
  16. Abu-Omar K, Rütten A, Robine JM. Self-rated health and physical activity in the European Union. Soz Praventivmed 2004; 49: 235-242. Go to original source... Go to PubMed...
  17. Goodwin RD. Association between physical activity and mental disorders among adults in the United States. Prev Med 2003; 36: 698-703. Go to original source... Go to PubMed...
  18. Steptoe A, Butler N. Sports participation and emotional well-being in adolescents. Lancet 1996; 347: 1789-1792. Go to original source... Go to PubMed...
  19. Weyerer S. Physical activity and depression in the community: evidence from the Upper Bavarian field study. Int J Sports Med 1992; 13: 492-496. Go to original source... Go to PubMed...
  20. Stephens T. Physical activity and mental health in the United Stats and Canada: evidence from four popular surveys. Prev Med 1988; 17: 35-47. Go to original source... Go to PubMed...
  21. Stathpoulou G, Powers MB, Berry AC, et al. Exercise interventions for mental health: a quantitative and qualitative review. Clin Psychol Sci Pract 2006; 13: 179-193. Go to original source...
  22. Ströhle A, Höfler M, Pfister H, et al. Physical activity and prevalence and incidence of mental disorders in adolescents and young adults. Psychol Med 2007; 37(11): 1657-1666. Go to original source... Go to PubMed...
  23. Ströhle A, Feller C, Onken M, et al. The acute antipanic activity of aerobic exercise. Am J Psychiatry 2005; 162: 2376-2378. Go to original source... Go to PubMed...
  24. Broocks A, Bandelow B, Pekrun G, et al. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry 1998; 155: 603-609. Go to original source... Go to PubMed...
  25. O´Connor P. State anxiety is reduced after maximal and submaximal exercise among people with panic disorder. Int J Sport Exerc Psychology 2005; 4: 501-508. Go to original source...
  26. Taylor A. Physical activity, anxiety and stress. In: Biddle S, Fox K, Boutcher S, eds: Physical activity and psychological wellbeing. London: Routledge 2000: 10-45.
  27. Petruzzello SJ, Landers AC, Hatfield BD, et al. A metaanalysis on the anxiety-reducing effect of acute and chronic exercise: outcomes and mechanisms. Sports Med 1991; 11: 143-182. Go to original source... Go to PubMed...
  28. Stich WA. A meta-analysis of physical exercise as a treatment for symptoms of anxiety adults from the general population. J Psychosom Res 1998; 33: 537-547.
  29. Steptoe A, Edwards S, Moses J, Mathews A. The effects of exercise training on mood and perceived coping ability in anxious adults from the general population. J Psychosom Res 1989; 33: 537-547. Go to original source... Go to PubMed...
  30. McEntee DJ, Halgin RP. Cognitive group therapy and aerobic exercise in the treatment of anxiety. J Coll Stud Psychoter 1999; 13(3): 39-58. Go to original source...
  31. Merom D, Phongsavan P, Wagner R, et al. Promoting walking as an adjunct intervention to group cognitive behavioral therapy for anxiety disorders: a pilot group randomized trial. J Anxiety Disord 2007; 22(6): 959-968. Go to original source... Go to PubMed...
  32. Manger TA, Motta RW. The impact of an exercise program on posttraumatic stress disorder, anxiety, and depression. Int J Emerg Ment Health 2005; 7: 49-57. Go to PubMed...
  33. Brown RA, Abrantes AM, Strong DR, et al. A pilot study of moderate-intensity aerobic exercise for obsessive compulsive disorder. J Nerv Ment Disease 2007; 195(6): 514-520. Go to original source... Go to PubMed...
  34. Abrantes AM, Strong DR, Cohn A, et al. Acute changes in obsessions and compulsions following moderate-intensity aerobic exercise among patients with obsessive-compulsive disorder. J Anxiety Depression 2009; 23: 923-927. Go to original source... Go to PubMed...
  35. Charney DS. Psychobiological mechanisms of resilience and vulnerability: Implication for successful adaptation to extreme stress. Am J Psychiatry 2004; 161: 195-216. Go to original source... Go to PubMed...
  36. Marks I. Treatment of panic disorder. Am J Psychiatry 1999; 156: 1129-1130. Go to original source... Go to PubMed...
  37. Ströhle A. Physical activity, exercise, depression and anxiety disorders. J Neural Transm 2009; 116: 777-784. Go to original source... Go to PubMed...
  38. Groves JO. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 2007; 12: 1079-1088. Go to original source... Go to PubMed...
  39. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression and antidepressant medications: metaanalyses and implications. Biol Psychiatry 2008; 64: 527-532. Go to original source... Go to PubMed...
  40. Gómez-Pinilla F, Vaynman S, Ying Z. Brain-derived neurotrophic factor functions as a metabotrophin to mediate the effects of exercise on cognition. Eur J Neurosci 2008; 28: 2278-2287. Go to original source... Go to PubMed...
  41. Kobayashi K, Shimizu E, Hashimoto K, et al. Serum brainderived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group behavioral therapy. Progr Neuropsychopharmacol Biol Psychiatry 2005; 29: 658-663. Go to original source... Go to PubMed...
  42. Kosová J, Hofmannová L, Vrubelová H. Group attendance CBT program decreases number of relapses in patient with anxiety disorders and improves their quality of life. ISAD, Cape Town; 14.-17. 3. 2008.




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.